Ropes & Gray has advised Eli Lilly and Company. Latham & Watkins has advised AtaiBeckley Inc. Eli Lilly and Company (NYSE: LLY) has entered into a...
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal
Serapha Bio and Boundless Bio Announce Merger and $230 Million Private Placement
Gibson Dunn has advised Serapha Bio, Inc. Latham & Watkins has advised Boundless Bio, Inc. Serapha Bio, Inc., a privately held biotechnology company, and Boundless Bio,...
Brookfield to Acquire Peakstone Realty Trust in $1.2 Billion Take-Private Deal
Latham & Watkins LLP and O’Melveny & Myers have advised Peakstone Realty Trust. Gibson, Dunn & Crutcher LLP and Thompson Hine LLP advised Brookfield Asset Management....
Summit Partners Makes Growth Investment in RIS Rx
Kirkland & Ellis along with DLA Piper has advised Summit Partners on the transaction, and Latham & Watkins has advised RIS Rx. Summit Partners has announced...
e.l.f. Beauty’s $1 Billion Acquisition of rhode
Latham & Watkins has advised e.l.f. Beauty, Skadden has advised rhode, and Cravath, Swaine & Moore has advised Hailey Bieber on the deal. e.l.f. Beauty has...
Boston Scientific’s $1.26 Billion Acquisition of Silk Road
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
Amphenol Corp.’s $2.025 Billion Acquisition of Carlisle Interconnect Technologies
Kirkland & Ellis is advising Carlisle Companies Incorporated on the transaction, and Latham & Walkins is advising Amphenol Corporation. Amphenol Corporation (NYSE: APH), a leading global...